* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Thursday, August 21, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Bama Dining Serving Up New Food, Entertainment – UA News Center

    Bama Dining Launches Thrilling New Food and Entertainment Experiences

    The latest on Williams-Brice Stadium renovations, entertainment district – On3

    Discover the Thrilling New Upgrades Coming to Williams-Brice Stadium and Its Vibrant Entertainment District!

    1000+ Entertainment Leaders Release Open Letter Criticizing TIFF’s Handling of Film – Creative Community for Peace

    1000+ Entertainment Leaders Release Open Letter Criticizing TIFF’s Handling of Film – Creative Community for Peace

    ‘The Lucky Ones’: Mae Ngai Sells Film & TV Rights To Neurosphere Entertainment – Deadline

    The Lucky Ones’: Mae Ngai Lands Thrilling Deal for Film and TV Adaptations

    Our picks for the best things to do in Cincinnati this week, Aug. 18-24 – Cincinnati Enquirer

    Unmissable Things to Do in Cincinnati This Week, Aug. 18-24

    Terence Stamp: from arthouse icon to blockbuster villain – yahoo.com

    Terence Stamp: From Arthouse Legend to Hollywood’s Ultimate Villain

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Denver man receives pacemaker using new technology – CBS News

    Denver Man’s Life Transformed by Revolutionary Pacemaker Technology

    Morgan County Rescue Squad is using new technology to recover people missing in the water faster – WAFF

    Morgan County Rescue Squad is using new technology to recover people missing in the water faster – WAFF

    YSU to celebrate launch of new radiology technology program – WKBN.com

    YSU Launches Exciting New Radiology Technology Program Celebration

    Thaddeus Stevens College of Technology kicks off return to school for Lancaster County colleges [photos] – LancasterOnline

    Thaddeus Stevens College of Technology Kicks Off an Exciting New School Year for Lancaster County Colleges [Photos]

    Empyrean Technology’s revenue climbs, but profit plunges 92% in EDA spending squeeze – digitimes

    Empyrean Technology’s Revenue Skyrockets as Profits Plunge 92% Amid EDA Spending Crunch

    5G-A technology provides strong support for China’s football sensation Suchao – Global Times

    How 5G-A Technology is Revolutionizing China’s Football Star Suchao

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Bama Dining Serving Up New Food, Entertainment – UA News Center

    Bama Dining Launches Thrilling New Food and Entertainment Experiences

    The latest on Williams-Brice Stadium renovations, entertainment district – On3

    Discover the Thrilling New Upgrades Coming to Williams-Brice Stadium and Its Vibrant Entertainment District!

    1000+ Entertainment Leaders Release Open Letter Criticizing TIFF’s Handling of Film – Creative Community for Peace

    1000+ Entertainment Leaders Release Open Letter Criticizing TIFF’s Handling of Film – Creative Community for Peace

    ‘The Lucky Ones’: Mae Ngai Sells Film & TV Rights To Neurosphere Entertainment – Deadline

    The Lucky Ones’: Mae Ngai Lands Thrilling Deal for Film and TV Adaptations

    Our picks for the best things to do in Cincinnati this week, Aug. 18-24 – Cincinnati Enquirer

    Unmissable Things to Do in Cincinnati This Week, Aug. 18-24

    Terence Stamp: from arthouse icon to blockbuster villain – yahoo.com

    Terence Stamp: From Arthouse Legend to Hollywood’s Ultimate Villain

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Denver man receives pacemaker using new technology – CBS News

    Denver Man’s Life Transformed by Revolutionary Pacemaker Technology

    Morgan County Rescue Squad is using new technology to recover people missing in the water faster – WAFF

    Morgan County Rescue Squad is using new technology to recover people missing in the water faster – WAFF

    YSU to celebrate launch of new radiology technology program – WKBN.com

    YSU Launches Exciting New Radiology Technology Program Celebration

    Thaddeus Stevens College of Technology kicks off return to school for Lancaster County colleges [photos] – LancasterOnline

    Thaddeus Stevens College of Technology Kicks Off an Exciting New School Year for Lancaster County Colleges [Photos]

    Empyrean Technology’s revenue climbs, but profit plunges 92% in EDA spending squeeze – digitimes

    Empyrean Technology’s Revenue Skyrockets as Profits Plunge 92% Amid EDA Spending Crunch

    5G-A technology provides strong support for China’s football sensation Suchao – Global Times

    How 5G-A Technology is Revolutionizing China’s Football Star Suchao

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

High Response Rates With Gene Therapies for BCG-Unresponsive Bladder Cancer

May 5, 2024
in Health
High Response Rates With Gene Therapies for BCG-Unresponsive Bladder Cancer
Share on FacebookShare on Twitter

SAN ANTONIO — More than 70% of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) achieved complete responses to a novel gene therapy, a small preliminary trial showed.

Across a range of doses, 16 of 22 patients had a complete response to detalimogene voraplasmid (EG-70), including 15 at 3 months and 10 at 6 months. Additionally, seven of 10 patients treated with the recommended phase II dose had complete responses. A majority of the responses persisted for 3-6 months.

About half of patients had treatment-related adverse events (TRAEs), only one of which reached grade 3 severity, reported Gordon Brown, DO, of Summit Health in Voorhees, New Jersey, at the American Urological Association annual meeting.

“Interim data from the phase I portion of the LEGEND study suggest a promising safety, tolerability, and efficacy profile,” said Brown. “Reported TRAEs are mostly grade 1/2 and consistent with catheterization/intravesical administration. As a noninfective gene therapy, there are no special handling precautions, patient restrictions post-treatment or ultra-cold chain logistics considerations. The treatment was delivered effectively and easily within our clinics, using our existing infrastructure without burdensome changes.”

Updated trial results for an adenoviral oncolytic gene therapy continued to show promising safety and efficacy. Cretostimogene grenadenorepvec led to complete responses in three-fourths of 105 evaluable patients with BCG-unresponsive NMIBC. Among patients followed for at least a year, more than 80% of the responses lasted at least 12 months, reported Mark Tyson, MD, of the Mayo Clinic in Scottsdale, Arizona.

NMIBC accounts for about 80% of all newly diagnosed bladder cancers, and about 30% of the cases have high-risk features. Intravesical instillation of BCG is standard of care for high-risk patients, but the disease recurs or progresses in half of cases (BCG unresponsive). Patients with recurrent/progressive disease have limited options beyond radical cystectomy, which remains standard of care to prevent progression to muscle-invasive bladder cancer, Brown noted in his introductory comments.

EG-70 is a nonintegrating, nonviral gene therapy designed for administration in any urology clinic. The therapy has a simplified preparation and administration process and requires no specialized storage or handling, reducing treatment burden for patients and clinic personnel, he continued.

EG-70 has a unique delivery vehicle containing a DNA plasmid that encodes retinoic acid-inducible gene (RIG) 1 agonist and interleukin (IL)-12. Administered intravesically, the gene therapy transfects and stimulates the immune system in the bladder.

The RIG-1 agonist stimulates NK cells and suppressor cell attenuation to promote tumor killing and also stimulates T-cell recruitment and neo-antigen presentation, Brown explained. IL-12 activates T-cell dependent cytokine response to promote tumor killing and immune memory. Bladder-restricted production has the potential to drive a strong therapeutic effect while reducing the potential for systemic adverse events.

The phase I component of the LEGEND trial included 24 patients (22 evaluable for response), who received two or four doses of EG-70 per 12-week cycle. The primary endpoint was safety, and the secondary endpoint was efficacy at 3 months.

Laboratory studies showed dose-dependent levels of IL-12 protein in the urine of every patient but no clinically significant levels in plasma.

The safety profile of all 24 patients showed that TRAEs occurred in 13 patients, and all but one TRAE was grade 1 or 2. The only grade 3 TRAE was renal failure, which occurred in a patient with a history of renal failure. The most common TRAEs (any grade) were hematuria (12.5%), dysuria (12.5%), and micturition urgency, fatigue, nocturia, and pyrexia (8.3% each).

The efficacy results showed a 3-month complete response rate of 68% (70% in patients who received the recommended phase II dose). Brown said 11 of 15 complete responses at 3 months persisted for at least 3 months, including six of seven responses with the recommended phase II dose.

Enrollment in the phase II component of the study has begun, with an accrual target of 100 patients. Patients will receive four doses of EG-70 at weeks 1, 2, 5, and 8 of a 12-week cycle.

Results after enrollment of 105 patients in the BOND-003 trial of cretostimogene remained consistent with earlier reports after 34 patients and 66 patients. The latest results showed complete responses in 79 (75%) patients at any time during follow-up. Additionally, responses persisted for 12 moths or longer in 29 of 35 (83%) responding patients followed for at least a year, said Tyson.

The results with single-agent cretostimogene compared favorably with those of the CORE-001 trial that combined the gene therapy with pembrolizumab (Keytruda). The combination led to complete responses in 29 of 34 (85%) patients, and 14 of 16 (88%) patients followed for a year had a response duration ≥12 months. Results from other recent trials of novel therapies for BCG-unresponsive bladder cancer showed complete responses in 41-62% of patients.

The collective results with cretostimogene suggest the gene therapy has the potential to become backbone therapy in NMIBC, according to Tyson.

author['full_name']

Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined MedPage Today in 2007. Follow

Disclosures

The LEGEND study was supported by enGene.

Brown disclosed relationships with Astellas, Bayer, enGene, Janssen, mdxhealth, Sumitomo, Ferring, Lantheus, Novartis, Pfizer, UroGPO, and Veracyte.

BOND-003 was supported by CG Oncology.

Tyson disclosed no relationships with industry.

Primary Source

American Urological Association

Source Reference: Kalota S, et al “LEGEND: A phase I/II study of EG-70 (detalimogene voraplasmid), a novel, nonviral intravesical gene therapy for patients with BCG-unresponsive non-muscle invasive ladder cancer with carcinoma in situ” AUA 2024; Abstract P2-08.

Secondary Source

American Urological Association

Source Reference: Tyson MD, et al “Pivotal results from BOND-003: A single-arm study of intravesical cretostimogene grenadenorepvec for the treatment of high-risk, BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ” AUA 2024; Abstract P2-02.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/meetingcoverage/aua/109967

Tags: healthRatesResponse
Previous Post

What Do New Breast Cancer Screening Recs Say?

Next Post

No PSA Recurrence at 24 Months With Apalutamide Plus ADT After Radical Prostatectomy

Econ 101: A Compass for a Lost Country – The Daily Economy

Econ 101: Unlocking the Secrets to Building a Brighter Future

August 21, 2025
Bama Dining Serving Up New Food, Entertainment – UA News Center

Bama Dining Launches Thrilling New Food and Entertainment Experiences

August 21, 2025
Putting sleep at the center of health care – The University of Arizona

Transform Your Health by Putting Sleep at the Center of Your Wellness Routine

August 21, 2025
Trump’s remarkable statement against states’ rights – CNN

Trump’s remarkable statement against states’ rights – CNN

August 21, 2025
Protected seas help kelp forests bounce back from heatwaves – ScienceDaily

How Protected Seas Are Helping Kelp Forests Thrive After Devastating Heatwaves

August 20, 2025
Female Jumping Spiders Of Two Species Prefer The Sexy Red Males Of One, Leading To Hybridization – IFLScience

Female Jumping Spiders Show a Surprising Preference for Vibrant Red Males, Sparking Hybridization Between Species

August 20, 2025
Salmon and steelhead extinction threshold science, and the ocean fish of northeast Oregon – Idaho Capital Sun

Salmon and steelhead extinction threshold science, and the ocean fish of northeast Oregon – Idaho Capital Sun

August 20, 2025
Grange Fair provides learning opportunities for the farming lifestyle – WTAJ

Experience the Farming Lifestyle Up Close with Grange Fair’s Hands-On Learning!

August 20, 2025
Denver man receives pacemaker using new technology – CBS News

Denver Man’s Life Transformed by Revolutionary Pacemaker Technology

August 20, 2025
Fall Whaler Sports Teams Begin Preseason Practices – Nantucket Current

Fall Whaler Sports Teams Ignite Excitement with Dynamic Preseason Practices

August 20, 2025

Categories

Archives

August 2025
MTWTFSS
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (781)
  • Economy (803)
  • Entertainment (21,681)
  • General (16,581)
  • Health (9,842)
  • Lifestyle (814)
  • News (22,149)
  • People (804)
  • Politics (811)
  • Science (16,015)
  • Sports (21,301)
  • Technology (15,783)
  • World (784)

Recent News

Econ 101: A Compass for a Lost Country – The Daily Economy

Econ 101: Unlocking the Secrets to Building a Brighter Future

August 21, 2025
Bama Dining Serving Up New Food, Entertainment – UA News Center

Bama Dining Launches Thrilling New Food and Entertainment Experiences

August 21, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version